Ritter Pharmaceuticals (RTTR) Stock Rockets On Exploration

Ritter Pharmaceuticals RTTR Stock News

Reason #3: There Are Other Strategic Transactions Available

Even if a merger or acquisition doesn’t take place following the review of strategic alternatives, there are other alternatives available.

In the release, RTTR said that it would also be looking into asset sales, licensing deals and other potential transactions. While these wouldn’t lead to the immediate return that investors would see from an acquisition, they would lead to value growth.

At the end of the day, if the company were to sell an asset or two, it could use the funding to pay down debt and improve its balance sheet. The same could be true for licensing revenue, if a licensing deal is signed.

So, even if an acquisition didn’t happn, there’s still light at the end of the tunnel as a result of today’s news!

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story!

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required

Pages: 1 2 3 4

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.